毒素A型用于治疗早期患有小角度急性获得并发性食otropia的患者
Run-Ting Ma1, Die-Wen-Jie Hu1, Lian-Hong Zhou1
1Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China.
早期的肉毒素A (BTXA) 注射有效地治疗了小角度急性并发性食otropia (AACE). 延迟治疗 (>6个月) 会降低BTXA的疗效,影响长期的眼睛对齐和立体镜复原.
科学领域:
- 眼科医生 眼科 眼科
- 神经学 神经学
背景情况:
- 急性获得并发食otropia (AACE) 是一种影响眼睛对齐的疾病.
- 毒素A (BTXA) 是AACE的潜在治疗方法.
研究的目的:
- 评估BTXA在患有小角度AACE的患者中的疗效.
- 根据治疗的时间来比较结果.
主要方法:
- 72名AACE患者接受BTXA治疗的回顾性队列研究.
- 根据治疗开始至治疗时间 (≤6个月与>6个月) 分组的患者.
- 在多个随访点对食otropia偏差,眼睛对齐和刻板印象的分析.
主要成果:
- 早期治疗 (≤6个月) 导致6个月后 significantly更高的骨架病率 (94.74% vs 73.53%).
- 早期治疗组在注射后3个月和6个月显示出明显较小的偏差.
- 早期治疗也导致了更好的立体镜复苏 (80′′ vs. 200′′).
结论:
- 在早期的AACE中,BTXA具有小偏差 (≤25Δ) 的有效性.
- 延迟治疗超过6个月可能会降低BTXA的疗效.
- 及时的BTXA干预支持持续的眼睛对齐和改善立体视觉.
更多相关视频
12:25Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
Published on: January 6, 2018
06:19Comparison of Three Clinical Stereoscopic Methods for Measuring Binocular Visual Function During Amblyopic Treatment in Unilateral Amblyopia
Published on: September 27, 2024
相关概念视频
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Skeletal Muscle Relaxants: Therapeutic Uses
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Accessory Structures of the Eye
